rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6550
|
pubmed:dateCreated |
1995-11-14
|
pubmed:abstractText |
The Ets-1 proto-oncogene is a member of a transcription factor family characterized by homology to the v-ets oncogene. In adult mice, Ets-1 is expressed predominantly in lymphoid cells where it has been implicated in regulating transcription of lymphocyte-specific genes. Following T-cell activation, the specific DNA binding activity of Ets-1 is inactivated by transient phosphorylation, suggesting a function in the transition from the resting to activated state. Ets-1 has also been suggested to cooperate with the AP-1 transcription factor complex to mediate cellular growth factor responses. Here we show, by using RAG-2-deficient blastocyst complementation, that Ets-1 deficiency has dramatic, but different, effects on development and function of T- and B-lineage cells. Ets-1-deficient T cells were present in reduced numbers and were highly susceptible to cell death in vitro. In contrast, Ets-1-deficient B cells were present in normal numbers but a large proportion were IgM plasma cells. Our data demonstrate that Ets-1 is essential for maintenance of the normal pool of resting T- and B-lineage cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ETS1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Ets1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Protein c-ets-1,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ets,
http://linkedlifedata.com/resource/pubmed/chemical/Rag2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/V(D)J recombination activating...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0028-0836
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
377
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
635-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7566176-Animals,
pubmed-meshheading:7566176-Apoptosis,
pubmed-meshheading:7566176-B-Lymphocytes,
pubmed-meshheading:7566176-Blastocyst,
pubmed-meshheading:7566176-Cell Differentiation,
pubmed-meshheading:7566176-Cell Line,
pubmed-meshheading:7566176-Chimera,
pubmed-meshheading:7566176-DNA-Binding Proteins,
pubmed-meshheading:7566176-Mice,
pubmed-meshheading:7566176-Proteins,
pubmed-meshheading:7566176-Proto-Oncogene Protein c-ets-1,
pubmed-meshheading:7566176-Proto-Oncogene Proteins,
pubmed-meshheading:7566176-Proto-Oncogene Proteins c-ets,
pubmed-meshheading:7566176-Proto-Oncogenes,
pubmed-meshheading:7566176-Spleen,
pubmed-meshheading:7566176-Stem Cells,
pubmed-meshheading:7566176-T-Lymphocytes,
pubmed-meshheading:7566176-Transcription Factors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
|
pubmed:affiliation |
Howard Hughes Medical Institute, Children's Hospital, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|